Preferred Pharmaceuticals, Inc. has recalled 66 bottles of Duloxetine (Duloxetine Delayed-Release Capsules USP 30mg). The recall was initiated because tests found an impurity called N-nitroso-duloxetine at levels higher than the FDA's recommended limit. Duloxetine is a prescription medication used to treat conditions such as depression and anxiety. This recall affects 30-count bottles with lot number J2022G that were distributed in California, Florida, Oklahoma, Kansas, and Connecticut.
The capsules contain a nitrosamine impurity which is classified as a probable human carcinogen. While nitrosamines are common in water and foods, exposure to high levels over a long period may increase the risk of developing cancer.
You have 2 options:
Quantity: 66 bottles of 30 tablets; Rx only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.